Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.685 SEK | +5.50% |
|
+5.92% | -64.95% |
Chart calendar Oncopeptides AB
Upcoming events on Oncopeptides AB
Past events on Oncopeptides AB
2024-05-31 05:00 am | Annual General Meeting |
2024-05-30 03:00 am | Q1 2024 Earnings Call |
2024-05-30 02:00 am | Q1 2024 Earnings Release |
2024-05-29 | Redeye Growth Day |
2024-05-25 | Controversies in Multiple Myeloma World Congress |
2024-03-20 06:30 am | Redeye Theme: Commercialization in Life Science |
2024-02-27 03:00 am | Q4 2023 Earnings Call |
2024-02-27 02:00 am | Q4 2023 Earnings Release |
2024-01-24 07:07 am | Redeye Theme: Fight Cancer |
2023-11-08 03:00 am | Q3 2023 Earnings Call |
2023-11-08 02:00 am | Q3 2023 Earnings Release |
2023-08-10 03:00 am | Q2 2023 Earnings Call |
2023-08-10 02:00 am | Q2 2023 Earnings Release |
2023-05-25 09:00 am | Annual General Meeting |
2023-05-04 03:00 am | Q1 2023 Earnings Call |
2023-05-04 02:00 am | Q1 2023 Earnings Release |
2023-02-16 03:00 am | FY 2022 Earnings Call |
2023-02-16 02:00 am | FY 2022 Earnings Release |
2022-12-09 | American Society of Hematology Meeting - Poster No. 4799 |
2022-12-09 | American Society of Hematology Meeting - Poster No. 2673 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 7,60 - | 118 156 -24.22% | 8,36 6,88 21.53% | 35,2 38,8 -9.31% | 84,2 |
EBITDA Million SEK | Released Forecast Spread | -735 -678 -8.39% | -1 577 -1 495 -5.51% | -1 400 -1 411 0.81% | -332 -319 -4.15% | 0,00 -241 - | -241 |
EBIT Million SEK | Released Forecast Spread | -739 -685 -7.97% | -1 591 -1 494 -6.5% | -1 421 -1 331 -6.72% | -349 -319 -9.53% | -253 -234 -8.51% | -234 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -740 -684 -8.16% | -1 592 -1 495 -6.54% | -1 421 -1 332 -6.7% | -338 -319 -5.87% | -248 -236 -5.26% | -241 |
Net income Million SEK | Released Forecast Spread | -741 -684 -8.25% | -1 595 -1 481 -7.7% | -1 430 -1 302 -9.85% | -338 -319 -5.95% | -249 -236 -5.54% | -241 |
EPS SEK | Released Forecast Spread | -14,3 -13,6 -5.76% | -25,6 -23,3 -9.75% | -19,0 -17,9 -6.31% | -4,11 -3,63 -13.13% | -2,76 -2,07 -33.18% | -2,04 |
Announcement Date | 20/02/20 | 18/02/21 | 17/02/22 | 16/02/23 | 24/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 |
---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 22,7 - | 8,75 0,00 - | 0,00 0,00 - |
EBIT Million SEK | Released Forecast Spread | -98,9 -162 39.11% | -61,1 -66,0 7.38% | -88,9 -59,7 -48.79% |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -98,6 -162 39.28% | -59,6 -66,0 9.7% | -88,3 -59,7 -47.91% |
Net income Million SEK | Released Forecast Spread | -98,6 -162 39.28% | -59,8 -66,0 9.28% | -88,4 -59,7 -48.1% |
EPS SEK | Released Forecast Spread | -1,31 -2,15 39.07% | -0,79 -0,87 9.2% | -1,00 -0,72 -38.89% |
Announcement Date | 04/05/22 | 11/08/22 | 09/11/22 |
Past sector events for Oncopeptides AB
2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ONCO Stock
- Calendar Oncopeptides AB